IMARC Group, a leading market research company, has recently released a report titled “Angioplasty Balloons Market Report by Product Type (Normal Balloons, Cutting Balloons, Drug Eluting Balloons, Scoring Balloons), Application (Coronary Angioplasty, Peripheral Angioplasty), Material (Nylon, Polyurethane, Silicone Urethane Co-Polymers, and Others), End-User (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2025-2033”. The study provides a detailed analysis of the industry, including the global angioplasty balloons market share, trends, size, and industry trends forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global angioplasty balloons market size reached USD 2.52 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.20 Billion by 2033, exhibiting a growth rate (CAGR) of 2.7% during 2025-2033.

Request to Get the Sample Report:

https://www.imarcgroup.com/angioplasty-balloons-market/requestsample

Angioplasty Balloons Market Trends

The angioplasty balloons market is poised for significant growth in cardiovascular care. In 2023, heart disease will increase demand for less invasive treatments. By 2024, innovations like drug-eluting balloons and better imaging will boost outcomes and safety. This will drive growth.

Additionally, better healthcare access in emerging markets will draw more heart patients. The focus on heart health will boost demand and tech. It will also raise awareness of heart disease prevention and management. Thus, the market is set to grow, reflecting a global commitment to better heart health.

Market Dynamics 1: Rise in Cardiovascular Diseases

The angioplasty balloons market is growing due to more cardiovascular diseases (CVDs) worldwide. Unhealthy diets, lack of exercise, and high stress are key factors. This increases the need for treatments. By 2024, more patients will need angioplasty. So, healthcare providers will look for advanced devices, like angioplasty balloons. These balloons are vital for opening blocked arteries. They restore blood flow. Awareness of cardiovascular health also boosts demand for these balloons.

Moreover, technological advances have led to better products, like drug-eluting balloons. These balloons release medication to prevent artery re-blocking. As healthcare focuses on CVDs, the angioplasty balloon market will grow. It will offer new solutions for the aging population.

Market Dynamics 2: Technological Advancements and Product Innovation

Technological advancements drive the angioplasty balloons market. They lead to products that improve outcomes and safety. By 2024, expect better designs, materials, and delivery systems. Manufacturers aim for balloons that are tougher and deliver targeted therapies. For example, drug-eluting balloons combine mechanical and pharmacological benefits. They reduce artery re-narrowing risk.

Moreover, advanced imaging and monitoring systems are now enhancing procedure precision. These innovations are vital. They will meet the demand for safer, more effective heart treatments.

Market Dynamics 3: Growing Demand in Emerging Markets

The angioplasty balloon market is growing. There are increased healthcare investments in emerging markets. Countries in Asia-Pacific, Latin America, and the Middle East are seeing a rise in cardiovascular diseases. This trend is pushing governments and the private sector to improve healthcare and access to advanced treatments. technologies. By 2024, demand for angioplasty balloons in these areas is expected to rise.

More facilities will adopt minimally invasive treatments for cardiovascular diseases. Expanding health insurance and establishing cardiac care centers are making angioplasty more accessible. Also, awareness of heart health and training programs are boosting the market. Manufacturers are noticing the potential in these markets. They will likely adjust products and marketing to meet regional needs. This will increase demand for angioplasty balloons.

Angioplasty Balloons Market Report Segmentation:

By Product Type:

·         Normal Balloons

·         Cutting Balloons

·         Drug Eluting Balloons

·         Scoring Balloons

Normal balloons hold the majority of the market share due to their widespread use and established efficacy in routine angioplasty procedures.

By Application:

·         Coronary Angioplasty

·         Peripheral Angioplasty

Coronary angioplasty accounted for the largest market share as it is the most common procedure performed to treat coronary artery disease.

By Material:

·         Nylon

·         Polyurethane

·         Silicone Urethane Co-Polymers

·         Others

Based on the material, the market has been divided into nylon, polyurethane, silicone urethane co-polymers, and others.

By End User:

·         Hospitals

·         Ambulatory Surgery Centers

·         Others

Ambulatory surgery centers hold the majority of the market share because of the increasing preference for outpatient procedures that offer convenience and cost-effectiveness.

Regional Insights:

·         North America

·         Asia-Pacific

·         Europe

·         Latin America

·         Middle East and Africa

North America's dominance in the market is attributed to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and significant healthcare expenditure.

Competitive Landscape with Key Players:

The competitive landscape of the angioplasty balloons market size has been studied in the report with the detailed profiles of the key players operating in the market.

Some of These Key Players Include:

·         Abbott Laboratories

·         B. Braun Melsungen AG

·         BD (Becton, Dickinson, and Company)

·         Biotronik SE & Co. KG

·         Boston Scientific Corporation

·         Cardinal Health Inc.

·         Cook Medical LLC

·         Endocor GmbH & Co. KG

·         Johnson & Johnson

·         Medtronic Inc.

·         Terumo Corporation

Ask Analyst for Customized Report:

https://www.imarcgroup.com/request?type=report&id=2270&flag=C

Key Highlights of the Report:

·         Market Performance (2018-2023)

·         Market Outlook (2024-2032)

·         Market Trends

·         Market Drivers and Success Factors

·         Impact of COVID-19

·         Value Chain Analysis

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St

Brooklyn, NY 11249, USA

Website: imarcgroup.com

Email: sales@imarcgroup.com

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800